Gabriela's Ozempic Experience: Weight Management Uses, Evidence and UK Context

What can one person's Ozempic experience really tell you?

Gabriela's experience can tell you what she says happened to her, but it cannot tell you how Ozempic will affect you, whether you are eligible for treatment, or which semaglutide medicine is appropriate for you.

For UK adults aged 18 and over looking for information about Ozempic, semaglutide medicines and their role in type 2 diabetes or weight management, it is important to look beyond personal stories. The authorised use of the medicine, MHRA information, NICE guidance and an individual clinical assessment all matter when deciding whether a treatment is suitable.

Ozempic is one of the best known medicines in the GLP 1 medicine group. It contains the active ingredient semaglutide and is a GLP 1 receptor agonist. In the UK, Ozempic is authorised for the treatment of type 2 diabetes, rather than specifically for weight management.

The MHRA distinguishes between different semaglutide products and their authorised uses. Ozempic and Rybelsus are semaglutide medicines authorised for type 2 diabetes, while Wegovy is authorised for weight management in eligible people.

That distinction is important.

It means:

Ozempic contains semaglutide

and

Wegovy contains semaglutide

but

they should not be treated as interchangeable products simply because they contain the same active ingredient.

The UK weight management landscape has also changed during 2026. On 11 June 2026, the MHRA approved Wegovy semaglutide tablets for weight loss and weight management in eligible adults. This became the first GLP 1 receptor agonist tablet approved in the UK specifically for weight management.

Key things to know

Ozempic is:

a GLP 1 receptor agonist medicine

containing:

semaglutide.

GLP 1 is not another name for Ozempic.

GLP 1 is a naturally occurring hormone. GLP 1 receptor agonists are medicines that act on this hormone pathway.

Semaglutide is one medicine in this group.

Ozempic is one product containing semaglutide.

For weight management in the UK, the exact product and its authorised indication matter. It is not enough to simply know that a medicine contains semaglutide.

What Is Ozempic?

Ozempic is a prescription medicine containing semaglutide.

Semaglutide belongs to a group of medicines known as:

GLP 1 receptor agonists.

The medicine is used alongside diet and exercise to treat adults with type 2 diabetes when blood glucose is not adequately controlled.

Ozempic is given as an injection under the skin.

Because several medicines contain semaglutide, it is important not to assume that they all have the same authorised uses or treatment instructions. The product information for each medicine should be followed.

Is Ozempic a GLP 1?

Yes.

Ozempic is a GLP 1 receptor agonist.

More precisely:

GLP 1 is the natural hormone.

GLP 1 receptor agonists are a group of medicines designed to act on the GLP 1 pathway.

Semaglutide is one active medicine in that group.

Ozempic is one product containing semaglutide.

The relationship can therefore be written as:

GLP 1 pathway

↓

GLP 1 receptor agonist medicine class

↓

semaglutide

↓

Ozempic.

This distinction can help answer searches such as:

"is GLP 1 the same as Ozempic?"

"is GLP 1 Ozempic?"

and

"Ozempic GLP 1".

Is GLP 1 the Same as Ozempic?

No.

Ozempic is one GLP 1 receptor agonist medicine, but GLP 1 is not simply another name for Ozempic.

Several medicines act through the GLP 1 pathway. In the UK, licensed medicines include semaglutide, liraglutide and tirzepatide. Tirzepatide acts on both GLP 1 and GIP pathways. Different medicines have different authorised uses, doses and treatment instructions.

Therefore:

all references to Ozempic involve a GLP 1 receptor agonist medicine

but

not every GLP 1 receptor agonist medicine is Ozempic.

What Is GLP 1?

GLP 1 stands for:

glucagon like peptide 1.

It is a naturally occurring hormone released by the body after eating.

GLP 1 has several roles in the body, including helping with blood glucose regulation and influencing appetite and feelings of fullness. GLP 1 receptor agonist medicines are designed to act on this pathway for therapeutic purposes.

Natural GLP 1 is part of normal human physiology. GLP 1 medicines are designed to produce a longer lasting effect on the same receptor pathway.

How Does Semaglutide Affect Appetite?

Semaglutide acts on GLP 1 receptors.

GLP 1 medicines can affect areas of the body and brain involved in appetite and food intake. Some people may feel fuller for longer or experience less hunger while taking semaglutide. However, the effect can vary between individuals.

When semaglutide is used for an authorised weight management indication, it is used alongside a reduced calorie diet and increased physical activity. The aim is to support weight management as part of a wider treatment plan, rather than relying on the medicine alone.

Does Ozempic Cause Weight Loss?

Some people taking Ozempic may lose weight.

Weight reduction has been observed with semaglutide when it is used as part of type 2 diabetes treatment. However, this does not mean that Ozempic is authorised as a weight management medicine in the UK. Its current UK indication is the treatment of adults with type 2 diabetes alongside diet and exercise.

This distinction matters because a medicine can have an effect on body weight without every product containing that medicine being authorised specifically for weight management.

For UK weight management, Wegovy is the semaglutide product authorised for this purpose in eligible people.

Is Ozempic Licensed for Weight Loss in the UK?

Ozempic is not the semaglutide product authorised specifically for weight management in the UK.

Current MHRA information distinguishes:

Ozempic: semaglutide authorised for type 2 diabetes.

Rybelsus: semaglutide authorised for type 2 diabetes.

Wegovy: semaglutide authorised for weight management in eligible people, with additional authorised uses for certain patients.

For someone searching "Ozempic UK weight loss", this is one of the most important distinctions to understand.

The fact that Ozempic and Wegovy both contain semaglutide does not make them the same product or give them the same authorised indication.

Why Does Ozempic Have Such a Strong Association With Weight Loss?

Why has the name Ozempic become so closely linked with weight loss when that is not its UK weight management indication?

There are a few reasons.

Semaglutide can affect appetite and body weight, and people taking Ozempic for type 2 diabetes may experience weight loss.

At the same time, Ozempic has received a great deal of:

• media attention
• social media attention
• celebrity discussion
• personal experience coverage.

This has led to "Ozempic" sometimes being used online as though it means:

any GLP 1 medicine

or

any semaglutide weight management treatment.

For UK healthcare purposes, those terms should remain separate. The medicine, indication and authorised use all matter.

What Is the Difference Between Ozempic and Wegovy?

Both contain:

semaglutide.

Both act on:

GLP 1 receptors.

But they are separate medicinal products with different authorised uses and product specific treatment instructions.

The MHRA identifies Ozempic as a semaglutide medicine authorised for type 2 diabetes and Wegovy as the semaglutide product authorised for weight management in eligible people.

You can learn more about Wegovy and its authorised weight management use.

So, while the active ingredient is the same, Ozempic and Wegovy should not be described as identical medicines. If you are considering semaglutide for weight management, the appropriate product and your eligibility should be assessed by a qualified prescriber.

Is Wegovy Just Ozempic for Weight Loss?

It is an easy assumption to make because both medicines contain semaglutide. But they are not simply the same medicine under different names.

They are separate medicinal products with their own:

• authorised indications
• formulations
• strengths
• dosing schedules
• prescribing information
• patient information.

The simpler way to put it is:

Wegovy and Ozempic both contain semaglutide, but Wegovy has a UK weight management indication, while Ozempic is authorised for the treatment of type 2 diabetes.

So, although they share the same active ingredient, you should not assume that one can be used in place of the other without appropriate clinical advice.

What Does NICE Recommend for Semaglutide Weight Management?

NICE recommends semaglutide as an option for weight management for certain adults who meet specific criteria.

For NHS treatment under NICE guidance, semaglutide is used alongside a reduced calorie diet and increased physical activity. NICE's recommendations include criteria based on BMI, weight related health conditions and access to specialist weight management services.

The NHS eligibility criteria are therefore not simply a matter of asking for "Ozempic for weight loss". The specific medicine, your health and your eligibility all need to be considered.

NICE guidance also uses lower BMI thresholds, usually reduced by 2.5 kg/m², when assessing eligibility for some people from certain ethnic backgrounds because weight related health risks can occur at a lower BMI.

This NICE recommendation relates to semaglutide used for weight management. It should not be taken to mean that Ozempic itself is a general weight loss medicine.

Is Ozempic Recommended by NICE for Type 2 Diabetes?

Yes, Ozempic has a role in NICE's treatment pathway for some adults with type 2 diabetes.

NICE updated its type 2 diabetes guidance in February 2026. The guidance includes subcutaneous semaglutide, specifically Ozempic, among the GLP 1 receptor agonists used in type 2 diabetes treatment. Treatment choices depend on the person's individual circumstances and diabetes management needs.

This is another useful way to understand the difference:

Ozempic: authorised for type 2 diabetes.

Wegovy: authorised for weight management in eligible people.

The active ingredient is the same, but the products and their authorised uses are different.

Can Someone Without Diabetes Use Ozempic Just to Lose Weight?

Ozempic should not be treated as a general purpose weight loss injection.

The MHRA advises that GLP 1 medicines should be used for their appropriate authorised medical purposes and warns against using these medicines simply for quick or cosmetic weight loss.

If you are looking for medical weight management, a prescriber can assess your health, BMI, medical history and other factors to determine whether a medicine authorised for weight management is appropriate.

What Are Weight Loss Drugs Like Ozempic?

When people search for "weight loss drugs like Ozempic", they are usually looking for medicines that affect appetite, blood glucose or related hormone pathways.

UK weight management options include medicines containing:

semaglutide

and medicines that act through:

GLP 1 and GIP pathways.

There are also weight management medicines that work in different ways.

Rather than comparing medicines simply by their brand names, it is more useful to look at:

• active ingredient
• authorised indication
• clinical eligibility
• how the medicine is given
• dosing schedule
• potential adverse effects
• other medicines and health conditions.

So, if you are searching for "something like Ozempic", do not assume that all GLP 1 medicines are interchangeable.

Are All Medicines Like Ozempic Injections?

No.

This changed significantly in 2026.

On 11 June 2026, the MHRA approved the UK's first GLP 1 receptor agonist tablet specifically for weight loss and weight management. The tablet contains semaglutide and is part of the Wegovy product line.

Then, on 10 August 2026, the MHRA authorised orforglipron, marketed as Foundayo, as another oral GLP 1 receptor agonist for weight management and type 2 diabetes in eligible adults.

So:

GLP 1 medicine

does not automatically mean

injection.

There are now oral GLP 1 medicines authorised in the UK, as well as injectable options.

Are There Ozempic Weight Loss Pills?

Ozempic itself should not be described as a weight loss pill.

Ozempic is a semaglutide injection authorised for type 2 diabetes.

However, there are now oral GLP 1 medicines authorised for weight management in the UK.

One important development was the Wegovy semaglutide tablet, which was approved by the MHRA on 11 June 2026 for weight loss and weight management in eligible adults.

This means the more accurate answer to a search such as "weight loss pills Ozempic" is:

Ozempic is not a weight loss pill, but oral GLP 1 weight management medicines are now available as authorised options in the UK.

Is Oral Semaglutide the Same as Ozempic?

No.

The active ingredient may be the same, but the product, route of administration and authorised purpose matter.

Ozempic is given as an injection.

The newly authorised weight management semaglutide tablet is a Wegovy product.

Do not try to work out a tablet dose from an Ozempic injection dose yourself.

The doses and instructions for each formulation are product specific. If a prescriber decides that switching is appropriate, they should explain how the change should be made.

What Is the New Wegovy Tablet?

The MHRA approved the first GLP 1 weight management tablet in the UK on 11 June 2026.

It contains:

semaglutide.

It is used alongside:

• a reduced calorie diet
• increased physical activity.

The authorised population includes adults with:

BMI of 30 or above

or

BMI from 27 to below 30 with at least one weight related health condition.

The tablet has its own dosing schedule and should be taken according to the prescribing information. It should not be treated as a tablet version of an Ozempic injection with an interchangeable dose.

NHS access is a separate question from MHRA authorisation. NICE and NHS commissioning arrangements determine how medicines are recommended and funded within NHS services.

What Is Orforglipron?

Orforglipron is another oral GLP 1 receptor agonist.

The MHRA authorised it in the UK on 10 August 2026 under the brand name Foundayo for weight management and type 2 diabetes. For weight management, it is authorised alongside a reduced calorie diet and increased physical activity in eligible adults.

This is another example of why "GLP 1" and "injection" should not automatically be treated as the same thing.

It also shows why the exact medicine matters. Orforglipron is a different active ingredient from semaglutide, even though both medicines act on the GLP 1 pathway.

Is Ozempic Better Than Other GLP 1 Medicines?

There is no useful universal ranking.

The appropriate medicine depends on what is being treated and the person's individual circumstances.

For example, someone being treated for type 2 diabetes may have different treatment priorities from someone being assessed specifically for weight management.

A prescriber may consider factors such as:

• authorised indication
• BMI
• weight related health conditions
• blood glucose control
• cardiovascular health
• medical history
• contraindications
• other medicines
• potential adverse effects
• treatment preferences.

The medicine that receives the most attention on social media is not automatically the most appropriate option for an individual.

Can Ozempic Be Prescribed Online in the UK?

Prescription medicines can be supplied through legitimate online healthcare services when an appropriate clinical assessment has taken place.

An online consultation should still involve a proper assessment of whether the medicine is suitable for you. Prescription medicines should not be treated like ordinary retail products that anyone can purchase without clinical checks.

For weight management, the medicine prescribed should be appropriate for the person's clinical situation and the medicine's authorised use.

The MHRA has also warned about illegal and inappropriate online sales of GLP 1 medicines and advises people to obtain these medicines through legitimate healthcare routes.

Why Does the Exact Product Matter?

Because sharing an active ingredient does not make two medicines identical.

The exact product determines things such as:

• authorised indication
• formulation
• route of administration
• dosing schedule
• patient information
• regulatory status.

Semaglutide is used in more than one medicinal product.

Using "semaglutide", "Ozempic" and "Wegovy" as though they are interchangeable can therefore create confusion about what a medicine is actually authorised to treat.

Can You Switch From Ozempic to a Weight Management Medicine?

Sometimes a prescriber may decide that switching from one GLP 1 medicine to another is appropriate, but this should be managed as part of your clinical care.

The MHRA provides specific guidance on switching between GLP 1 medicines, including the need to consider the medicines involved and their dosing instructions.

A prescriber may need to consider:

• why the original medicine was prescribed
• current blood glucose control
• weight management eligibility
• treatment response
• current dose
• adverse effects
• other medicines
• your overall health.

Do not try to work out a dose conversion yourself or change medicines without speaking to your prescriber.

Some semaglutide products have specific instructions for transitioning between formulations, but the correct approach depends on the products involved.

Can You Use Two GLP 1 Medicines Together?

You should not combine GLP 1 medicines unless a qualified prescriber has specifically advised you to do so.

For example, the Wegovy product information states that semaglutide should not be used in combination with other GLP 1 receptor agonist products.

Taking more than one medicine that acts on the same pathway is not a safe way to try to increase weight loss.

If you are already taking a GLP 1 medicine and are considering another treatment, speak to your prescriber rather than adding or changing medicines yourself.

What Does an Ozempic Experience Tell You?

Personal experiences can help you understand what treatment felt like for one person.

Someone might describe:

• changes in hunger
• smaller portions
• nausea or other digestive symptoms
• changes in food preferences
• changes in body weight
• difficulties while adjusting to treatment.

These experiences can be interesting and sometimes helpful, but they cannot predict exactly what another person will experience.

People respond differently to medicines, and factors such as the dose, treatment duration, other medicines and individual health can all matter.

What About "Gabriela's Ozempic Experience"?

A search such as "Gabriela's Ozempic experience" reflects a common desire to understand a medicine through someone else's story.

An individual account can tell you what happened to that person, but it cannot establish:

• whether Ozempic is appropriate for you
• how much weight you would lose
• whether you would experience the same adverse effects
• which medicine you should use
• whether a particular medicine is authorised for your intended purpose.

Personal stories are anecdotal evidence. They can provide context, but they are not a substitute for clinical evidence or individual medical advice.

For UK treatment decisions, it is more useful to look at:

MHRA authorised uses

NICE guidance where applicable

and

an individual clinical assessment.

Why Do Ozempic Results Differ Between People?

It can be tempting to compare your results with someone else's, especially when social media is full of dramatic before and after stories. But one person's result does not set an expected result for everyone.

Individual response can vary because of differences in:

• starting body weight
• appetite and eating habits
• activity levels
• treatment duration
• dose
• medical conditions
• other medicines
• how consistently treatment is taken.

A large weight change reported online does not mean that everyone taking the same medicine will have the same result.

Equally, one person reporting little change does not mean that the medicine cannot work for other people.

If you are considering Ozempic, Wegovy or another GLP 1 medicine, the most useful starting point is not someone else's result. It is understanding what the specific medicine is authorised to treat and whether it is appropriate for your own health and circumstances.

Does Everyone Lose Weight on Ozempic?

No. Medicines do not produce exactly the same results in everyone.

Some people taking Ozempic may notice changes in appetite or body weight, while others may see a smaller change. The response can depend on factors such as the person's health, treatment plan and how they respond to the medicine.

Some people may also stop treatment because:

• adverse effects are difficult to manage
• treatment goals are not being met
• their treatment needs or circumstances change.

Treatment should be reviewed by an appropriate healthcare professional rather than judged by someone else's experience.

Is Faster Weight Loss Better?

Not necessarily.

Trying to lose weight faster by taking more medicine than prescribed is not a safe approach. The MHRA has warned people not to increase GLP 1 medicine doses beyond the prescribed instructions in an attempt to speed up weight loss. (gov.uk)

Dose increases are usually made gradually according to the specific medicine's prescribing information. This can help the body adjust to treatment and may reduce the risk of troublesome adverse effects.

Taking more than prescribed can increase the risk of adverse effects and does not guarantee greater or faster weight loss.

What Are Common GLP 1 Adverse Effects?

Stomach and digestive problems are among the most common adverse effects reported with GLP 1 medicines.

These can include:

• nausea
• vomiting
• diarrhoea
• constipation
• stomach pain or discomfort.

They may be more noticeable when treatment starts or when the dose is increased. The exact adverse effects and their frequency depend on the medicine you are taking, so always check the product information supplied with your treatment. (medicines.org.uk)

If an adverse effect is severe, persistent or worrying you, speak to your prescriber or another healthcare professional.

Can Ozempic Cause Serious Adverse Effects?

Like any prescription medicine, Ozempic has important safety considerations.

For example, semaglutide can increase the risk of hypoglycaemia, or low blood sugar, when it is used with insulin or certain other diabetes medicines. (medicines.org.uk)

In January 2026, the MHRA strengthened warnings about acute pancreatitis for GLP 1 receptor agonists and dual GIP and GLP 1 receptor agonists. (gov.uk)

Seek urgent medical advice if you develop severe, persistent abdominal pain, particularly if it spreads towards your back and is accompanied by nausea or vomiting.

Do not ignore severe or unusual symptoms simply because they may have started after taking a medicine. A healthcare professional can assess what is causing them.

What Is the 2026 Semaglutide Eye Safety Update?

On 5 February 2026, the MHRA updated the safety information for medicines containing semaglutide following a review of non arteritic anterior ischaemic optic neuropathy, known as NAION. NAION is a very rare eye condition that can cause sudden vision loss, usually in one eye. (gov.uk)

Semaglutide may also be associated with diabetic retinopathy complications in some people with diabetes. The Ozempic product information advises monitoring patients with a history of diabetic retinopathy, particularly when blood glucose control improves rapidly. (medicines.org.uk)

If you experience a sudden change or loss of vision, seek urgent medical assessment.

What If You Are Having an Operation?

If you take a GLP 1 medicine, tell your doctor, surgeon, anaesthetist or other healthcare professional before an operation or procedure.

GLP 1 medicines can delay stomach emptying. This may be relevant when general anaesthesia or deep sedation is being used because food or liquid remaining in the stomach can increase the risk of aspiration. (gov.uk)

Do not stop your medicine on your own because you have an operation planned.

Your healthcare team can decide whether any changes are needed and tell you how to manage your treatment safely.

Can GLP 1 Medicines Be Used During Pregnancy?

GLP 1 medicines used for weight management are not recommended during pregnancy.

For semaglutide medicines, women who are able to become pregnant should use contraception during treatment, and semaglutide should be stopped at least 2 months before a planned pregnancy. (medicines.org.uk)

Semaglutide should not be used during pregnancy because there are limited human safety data and animal studies have raised concerns about effects on pregnancy.

If you become pregnant while taking a GLP 1 medicine, contact your prescriber or another healthcare professional for advice.

Pregnancy and breastfeeding advice can differ between medicines, so check the specific product information rather than assuming that all GLP 1 medicines have identical instructions.

Does Ozempic Permanently Change Appetite?

Ozempic can affect appetite while you are taking it, but it should not be viewed as permanently resetting your appetite after treatment ends.

When treatment stops, appetite and eating habits may change again, and body weight can also change over time.

For medicines that are authorised for weight management, medication is generally used alongside dietary and physical activity changes rather than as the only part of treatment.

This is one reason why longer term weight management involves more than simply taking a medicine.

Can Weight Return After Semaglutide Is Stopped?

Yes, weight regain can occur after semaglutide treatment is stopped.

Clinical research has found that people can regain a substantial amount of weight after stopping semaglutide used for weight management. This does not mean that everyone will regain the same amount, but it shows why ongoing weight management may be needed. (pubmed.ncbi.nlm.nih.gov)

The factors that influence body weight do not disappear when treatment ends. For some people, ongoing dietary habits, physical activity and professional support may therefore remain important.

Does Using Ozempic Mean You Do Not Need Diet Changes?

No.

Ozempic is authorised in the UK for the treatment of type 2 diabetes alongside diet and exercise. (medicines.org.uk)

Medicines authorised specifically for weight management are also used alongside dietary and physical activity measures. The Wegovy semaglutide tablet, for example, is authorised for use with a reduced calorie diet and increased physical activity. (gov.uk)

Medication may help with appetite or blood glucose management, depending on the medicine and its indication. It does not make healthy eating and physical activity irrelevant.

Can Ozempic Be Used for Cosmetic Weight Reduction?

Ozempic should not be treated as a cosmetic slimming product.

The MHRA advises that GLP 1 medicines should only be used for their authorised medical purposes and warns against obtaining or using these medicines simply for rapid or cosmetic weight loss. (gov.uk)

Prescription treatment should be based on an appropriate clinical assessment rather than social media trends or a desire to copy another person's results.

Can Someone With a Normal BMI Use Ozempic for Weight Loss?

GLP 1 medicines should not be viewed as unrestricted slimming products.

Weight management medicines have specific eligibility criteria. For example, the Wegovy semaglutide tablet is authorised for eligible adults with:

BMI of 30 or above

or

BMI from 27 to below 30 with at least one weight related health condition. (gov.uk)

These criteria apply to the authorised weight management indication and should not be used as a personal diagnosis.

Wanting to lose a small amount of weight does not automatically mean that prescription weight management treatment is appropriate. A prescriber can look at your overall health and circumstances before recommending treatment.

What Should a Weight Management Assessment Check?

A proper consultation is about more than asking which medicine you would like.

An appropriate assessment may look at:

• weight
• height
• BMI
• relevant weight related health conditions
• previous weight management attempts
• current medicines
• medical history
• contraindications
• previous GLP 1 treatment
• treatment goals.

The purpose is to determine whether medical treatment is appropriate for you and, if so, which treatment and dose are suitable.

A prescriber should also explain the possible benefits, risks and adverse effects so that you can make an informed decision about treatment.

Can You Buy Ozempic From Social Media?

It is not safe to obtain prescription medicines from unregulated sellers on social media or other unofficial websites.

The MHRA has warned about counterfeit and illegally supplied GLP 1 medicines. Products obtained outside legitimate supply chains may not contain what the label says and may be incorrectly manufactured, stored or supplied. (gov.uk)

Unregulated products may be:

• falsified
• contaminated
• incorrectly dosed
• incorrectly labelled.

Use a legitimate healthcare provider and regulated pharmacy when obtaining prescription medicine.

How Do You Know Whether a GLP 1 Product Is Genuine?

The safest approach is to obtain prescription medicine through:

an appropriately regulated prescriber

and

a legitimate pharmacy.

Do not rely on:

• packaging photographs
• unusually low prices
• social media recommendations
• seller claims.

Counterfeit medicines can sometimes look very similar to genuine products, so appearance alone cannot confirm that a medicine is authentic.

If you are unsure about a medicine you have received, speak to a pharmacist or contact the relevant healthcare provider before using it.

Why Should You Not Share Ozempic?

Ozempic is a prescription medicine intended for the person it has been prescribed for.

Sharing it can bypass important checks such as:

• eligibility assessment
• dose selection
• contraindication checks
• adverse effect counselling
• monitoring.

Another person's medicine may not be suitable for you, even if you have a similar weight or health concern.

Never give your prescription medicine to someone else or use another person's medicine.

Ozempic vs Wegovy: UK Context

The active ingredient is only one part of a medicine's identity.

Ozempic and Wegovy both contain semaglutide, but they are separate products with different authorised uses and prescribing information. (medicines.org.uk)

Ozempic vs GLP 1: What Is the Correct Terminology?

If the terminology feels confusing, this is the easiest way to understand it:

GLP 1
A naturally occurring hormone in the body.

GLP 1 receptor agonist
A class of medicines that act on the GLP 1 receptor.

Semaglutide
An active medicine that acts as a GLP 1 receptor agonist.

Ozempic
A semaglutide product authorised in the UK for the treatment of type 2 diabetes.

Wegovy
A semaglutide product authorised in the UK for weight management in eligible people.

So, when you see searches such as:

"is GLP 1 the same as Ozempic?"

"is Ozempic GLP 1?"

and

"GLP 1 Ozempic",

the important point is that Ozempic is a GLP 1 receptor agonist medicine, but GLP 1 and Ozempic are not the same thing.